Borregaard Q2 revenue rises 3% to NOK 2.11 billion; profit turns to loss of NOK 123 million

• Borregaard posted Q2 operating profit of NOK 337 million, down 11% year on year, while EBITDA edged down 1% to NOK 515 million.
• Operating revenues rose 3% to NOK 2.11 billion, while the EBITDA margin narrowed 1.1 percentage points to 24.4%.
• Profit attributable to owners swung to a loss of NOK 127 million, hurt by a NOK 337 million impairment of the Alginor investment.
• Segment EBITDA fell 9% to NOK 306 million in BioSolutions, while BioMaterials rose 6% to NOK 151 million and Fine Chemicals jumped 41% to NOK 58 million.
• 2026 volume outlook: BioSolutions about 335,000 tonnes; BioMaterials expected to exceed 160,000 tonnes; Fine Chemicals intermediates volumes seen rising vs 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Borregaard ASA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.